Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-05 Sale |
2021-10-06 7:42 pm |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
610,092 | $0 | $0 | 0 (Direct) |
View |
| 2020-07-02 Sale |
2020-07-02 4:29 pm |
PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director |
13,194 | $18 | $237,492 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-19 Option Award |
2024-12-20 8:30 pm |
N/A 2034-12-19 |
Applied Therapeutics Inc. | APLT | JOHNSON JOHN Executive Chairman |
1,500,000 | $0 | 1,500,000 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 9:13 pm |
N/A N/A |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
11,904 | $0 | 29,016 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 8:27 pm |
N/A 2034-06-18 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
20,833 | $0 | 20,833 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 6:20 pm |
N/A 2034-06-06 |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
28,901 | $0 | 35,360 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 4:18 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
50,000 | $0 | 890,983 (Direct) |
View |
| 2024-03-15 Other |
2024-04-01 5:43 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
89,571 | $0 | 930,554 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-18 5:32 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
215,600 | $1.99 | 751,412 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-18 5:32 pm |
N/A 2029-11-14 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
215,600 | $0 | 751,412 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-13 6:14 pm |
N/A 2034-03-11 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
8,549 | $0 | 8,549 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-07 06:29 am |
N/A 2033-09-01 |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
32,340 | $0 | 32,340 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:59 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
42,500 | $0 | 535,812 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:53 pm |
N/A N/A |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
6,459 | $0 | 6,459 (Direct) |
View |
| 2023-05-15 Option Award |
2023-05-16 4:33 pm |
N/A 2033-05-15 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-05-12 Option Award(A) |
2022-12-20 4:07 pm |
N/A 2032-05-12 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:11 pm |
N/A 2032-06-22 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:13 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
40,000 | $0 | 518,312 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:14 pm |
N/A 2032-06-01 |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
18,270 | $0 | 18,270 (Direct) |
View |
| 2021-10-05 Option Award(A) |
2021-10-08 6:29 pm |
N/A 2031-10-05 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
19,650 | $2.37 | 886,609 (Direct) |
View |
| 2021-10-05 Option Award(A) |
2021-10-08 6:29 pm |
N/A 2025-10-16 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
866,959 | $0 | 886,609 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:52 pm |
N/A 2025-10-16 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
866,959 | $0 | 866,959 (Direct) |
View |
| 2021-10-01 Tax Withholding |
2021-10-05 7:24 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
334,868 | $2.06 | 610,092 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:10 pm |
N/A 2031-07-19 |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
27,638 | $0 | 27,638 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-07 5:01 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
50,867 | $3.08 | 944,960 (Direct) |
View |
| 2021-06-28 Option Award |
2021-06-30 2:00 pm |
N/A 2031-06-28 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 5:13 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
17,325 | $2.68 | 995,827 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 08:33 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
491,000 | $0 | 1,013,152 (Direct) |
View |
| 2020-07-02 Option Award |
2020-07-07 08:11 am |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer |
315,000 | $0 | 522,152 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 5:31 pm |
N/A 2030-06-16 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
27,602 | $0 | 27,602 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-15 6:59 pm |
N/A 2030-06-11 |
PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director |
18,658 | $0 | 31,852 (Direct) |
View |
| 2020-05-15 Tax Withholding |
2020-05-18 4:51 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Executive Chairman |
15,348 | $2.86 | 207,152 (Direct) |
View |
| 2020-04-29 Option Award |
2020-04-29 6:19 pm |
N/A 2030-04-29 |
Verastem Inc. | VSTM | JOHNSON JOHN Director |
25,000 | $0 | 25,000 (Direct) |
View |